Skip to main content
Caplight Logo









Optimale

Optimale

Private
LondonHealthcare & Life Scienceshttps://optimale.co.uk/

Last Round

Angel

Sep 11, 2025

Total Funding Raised

$194M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Optimale is a healthcare company that provides medical services, diagnostics, and testosterone replacement therapy (TRT) to patients in the United Kingdom.

Sector

Healthcare & Life Sciences

Verticals

Telemedicine, D2C Brands, Subscription Commerce

Business Model

B2C

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

telehealthtestosterone replacement therapyTRTmen's healthhormone optimizationlow testosteroneTRT clinicblood testingdiagnostic pathologyremote consultationsubscription healthcarehormonal healthdirect-to-consumer healthcareD2C telehealthonline TRT clinic

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Optimale Comparables

Compare Optimale with similar companies based on industry and business-model similarity.

Optimale comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Alphagenix Ltd
94%
Balance My Hormones Ltd
94%
Ted's Health
91%

Optimale Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelSep 11, 2025
DebtNov 1, 2024
Series BSep 15, 2024
Series AMar 30, 2021
SeedJan 15, 2019

Key People

Founding team and executive leadership

David Kennett

COO, Co-Founder

Founding Team

Optimale Investors

Notable investors and investment history

Optimale investors
InvestorRounds
CASSIUSSeed
WaldencastSeries A
Felix CapitalSeed, Series B, Series A
FJ LabsSeries A
Sonoma Brands CapitalSeries A
Octopus VenturesSeries B
Cherry VenturesSeed, Series B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2025

    Raised an Angel round with participation from James Smith.

  • Sep 15, 2024

    $38M round led by Cherry Ventures, Felix Capital, and Octopus Ventures.

Optimale Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Optimale Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Optimale's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range12
Year Founded2017
Last FundingSep 11, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?